NICOLE GARCIA: Open Payments
NPI 1609901792 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 39 payments from 15 companies in 2025. Trend: 2023 $289 · 2024 $472 · 2025 $920
Food & beverage: $886Education: $34
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $204 |
| BioCryst US Sales Co., LLC | 11 | $180 |
| GENZYME CORPORATION | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Genentech USA, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Amgen Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| PFIZER INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
Products named: DUPIXENT, ORLADEYO, Xolair, TEZSPIRE, CUVITRU, Rhapsido, PANZYGA, EBGLYSS.
Industry payments across FL — which companies pay providers there.
